Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

M. Alhaj Moustafa, S Vincent Rajkumar, Angela Dispenzieri, Morie Gertz, Martha Lacy, F. K. Buadi, Y. L. Hwa, David M Dingli, Prashant Kapoor, S. R. Hayman, J. A. Lust, R. A. Kyle, Shaji K Kumar

Research output: Contribution to journalArticle

15 Scopus citations


Normalization of the serum-free light-chain ratio (FLCr) with the absence of bone marrow monoclonal plasma cells following achievement of a complete response (CR) to therapy denotes a stringent CR in multiple myeloma (MM), and is associated with improved overall survival (OS). However, its value in patients achieving

Original languageEnglish (US)
Pages (from-to)2033-2038
Number of pages6
Issue number10
StatePublished - Oct 1 2015


ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this